Metastasis-suppressor genes in clinical practice: lost in translation? (Q37869335)

24 August 2017

1 reference

title

Metastasis-suppressor genes in clinical practice: lost in translation? (English)

1 reference

24 August 2017

author name string

Alexander N Shoushtari

series ordinal

1

1 reference

24 August 2017

Russell Z Szmulewitz

series ordinal

2

1 reference

24 August 2017

Carrie W Rinker-Schaeffer

series ordinal

3

1 reference

24 August 2017

language of work or name

English

0 references

publication date

26 April 2011

1 reference

Nature Reviews Clinical Oncology

24 August 2017

published in

1 reference

24 August 2017

volume

8

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

333-342

1 reference

Dissemination and growth of cancer cells in metastatic sites

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Cancer. The metastasis cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Seeding and propagation of untransformed mouse mammary cells in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The Nm23-H1 metastasis suppressor as a translational target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Learning therapeutic lessons from metastasis suppressor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Biomarkers in cancer staging, prognosis and treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Gene-expression signatures in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Clinical-translational approaches to the Nm23-H1 metastasis suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

NM23 as a prognostic biomarker in ovarian serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

RhoGDI2 expression is associated with tumor growth and malignant progression of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Mechanisms of disease: Oncogene addiction--a rationale for molecular targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prediction of distant metastases after curative surgery for rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of nm23 H-1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

nm23 Protein expression in larynx cancer and the relationship with metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Cytoplasmic expression of nm23 predicts the potential for cerebral metastasis in patients with primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic role of nm23 gene expression in patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Clinical significance of transmembrane 4 superfamily in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Frequent Down-Regulation and Lack of Mutation of the KAI1 Metastasis Suppressor Gene in Epithelial Ovarian Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Gene discovery in bladder cancer progression using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

A microRNA DNA methylation signature for human cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Endogenous human microRNAs that suppress breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Nanoparticle delivery of anti-metastatic NM23-H1 gene improves chemotherapy in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

KAI1 is a potential target for anti-metastasis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Snail is a repressor of RKIP transcription in metastatic prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Nm23 protein expression in ductal in situ and invasive human breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic implication of nm23-H1 expression in colorectal carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Protein Markers in Colorectal Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

nm23-H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic significance of co‐expression of nm23 and p57 protein in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of nm23 protein in pulmonary adenocarcinomas: inverse 1orrelation to tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Immunohistochemical expression of nm23 gene product, nucleotide diphosphate kinase, in pancreatic neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Loss of RKIP expression is associated with poor survival in GISTs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.65

Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival

31 March 2020

1 reference

12 December 2020

Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.

1 reference

12 December 2020

KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer

1 reference

12 December 2020

Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.

1 reference

12 December 2020

The role of nm23-H1 in the progression of transitional cell bladder cancer.

1 reference

12 December 2020

Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.

1 reference

12 December 2020

Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder

1 reference

12 December 2020

Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential

1 reference

12 December 2020

Increased sensitivity to cisplatin by nm23-transfected tumor cell lines

1 reference

12 December 2020

Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers

1 reference

12 December 2020

Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer.

1 reference

12 December 2020

Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.

1 reference

12 December 2020

KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.

1 reference

12 December 2020

Somatic allelic deletion of nm23 in human cancer

1 reference

12 December 2020

Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine

1 reference

12 December 2020

Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition

1 reference

12 December 2020

RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

1 reference

12 December 2020

The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.

1 reference

12 December 2020

Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer

1 reference

12 December 2020

Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.

1 reference

12 December 2020

Breast cancer. Clinical practice guidelines in oncology

1 reference

12 December 2020

Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling

1 reference

12 December 2020

NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.

1 reference

12 December 2020

Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis

1 reference

12 December 2020

1 reference

12 December 2020

Tumor heterogeneity and the biology of cancer invasion and metastasis

1 reference

12 December 2020

The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival

1 reference

12 December 2020

10.1038/NRCLINONC.2011.65

Identifiers

DOI

1 reference

24 August 2017

1 reference